Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

December 18, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

September 02, 2016

As the United States and other member countries of the G20 meet in Hangzhou, China, September 4-5, Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to address the failures of medical research and development (R&D) to deliver medicines, vaccines and diagnostics that match the health needs of people around the world instead of only focusing on the most lucrative products.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

November 30, 2015

JOHANNESBURG/HARARE—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today warned that lifesaving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa, most often despite sufficient stocks already being present in countries, and called for urgent improvements in ARV supply chains in the region.

March 06, 2014

Boston/New York, March 6, 2014—Two new studies released today by Epicentre,the research arm of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at CROI, the Conference on Retroviruses and Opportunistic Infections, point to reductions in new HIV infections in areas where HIV treatment has been greatly expanded. The studies are some of the first to look at large-scale antiretroviral therapy (ART) rollout in real-world high-HIV-burden settings in sub-Saharan Africa, and its possible impact on reducing new infections.

November 21, 2011

Without appropriate funding, the opportunity to reap the benefits of new science showing that HIV treatment both saves lives and helps prevent new infections could be lost.

September 12, 2011

As the Measles Initiative meets in Washington, D.C., MSF is calling for an effective outbreak response mechanism to be established immediately to deal with the rising numbers of severe outbreaks worldwide. 

May 11, 2011

While several countries hardest hit by HIV/AIDS are improving treatment protocols to reduce deaths and illness, a lack of donor support still prevents many from implementing vital changes.

December 07, 2010

Several low-income countries highly affected by HIV risk being entirely or partly disqualified from the current funding round by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Pages